FDA
-
-
-
-
-
-
-
BeOne Medicines wins FDA approval for mantle cell lymphoma drug
-
-
-
-
-
-
-
ZIIHERA Plus TEVIMBRA and Chemotherapy: A Potential New Standard for First-Line HER2+ Advanced GEA
-
-
-
-
-
-
-
BeOne Medicines Showcases Leadership in B-cell Malignancies at ASH 2025
-
-
-
-
-
-
-
BeOne Medicines Announces Positive Topline Results for Sonrotoclax in Relapsed or Refractory Mantle Cell Lymphoma (MCL)
-
-
-
-
-
-
-
Oncolytics Biotech® Announces Upcoming Annual General Meeting and Second Quarter Financial Results
-
-
-
-
-
-
-
Oncolytics Biotech® Regains Compliance with Nasdaq Trading Rules
-
-
-
-
-
-
-
BeOne Medicines Showcases Breakthrough Data in CLL and MCL at EHA 2025
-
323,573 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

